Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2009-02-08 Report Publication Anno…
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Immediate Report
Report Publication Announcement Classification · 95% confidence The document is an 'Amended report' transmitted on 08/02/2009, referencing a previous report about an 'Extra Ordinary Meetings' (EGM). It explicitly states, 'Attached hereto is a report on *an updated press release- Company's Extra Ordinary Meetings*'. Since the document itself is an announcement regarding the publication of materials related to an EGM (which involves shareholder voting and meeting information), and given its short length (2089 chars) and the mention of an attached PDF press release, it fits the description of a Report Publication Announcement (RPA) or potentially related to AGM/EGM materials. However, the core subject is the announcement of the updated EGM press release/materials. The closest specific category for materials related to general meetings is AGM-R (AGM Information), but since this is an *amendment* to a report about an *Extra Ordinary Meeting* press release, and it functions as a notification of publication, RPA is a strong candidate. Given the context of an EGM amendment and the attachment of a press release, it is most accurately classified as an announcement regarding the publication of meeting-related information. If the content were the actual voting results, it would be DVA. If it were the proxy materials, it would be PSI. Since it is an amendment to a press release about the EGM, and it is a short notification, RPA (Report Publication Announcement) is the most appropriate general announcement category, though AGM-R is also relevant to the subject matter. Given the structure, it is an announcement about a report/press release, making RPA the best fit based on Rule 2.
2009-02-08 English
Annual General Meeting / Special Meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for use at two Extraordinary General Meetings (EGMs) of XTL Biopharmaceuticals Ltd. It includes instructions for shareholders to appoint proxies to vote on various resolutions, including appointments of directors, share capital changes, and remuneration terms. The document is procedural and related to voting at a shareholder meeting, not a report or announcement of results. It is not an announcement of voting results but a solicitation for proxy votes. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is 5688 characters, which is consistent with a detailed proxy form rather than a brief announcement or report.
2009-02-08 Hebrew (modern)
Annual General Meeting / Special Meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of two Extraordinary General Meetings (EGMs) of XTL Biopharmaceuticals Ltd. It includes information about the convening of the meetings, the agenda items such as replacement and appointment of directors, remuneration to directors, consolidation and increase of share capital, and amendment of ADR ratios. It also provides instructions to shareholders on proxy voting and details about the directors seeking appointment. The document is not a financial report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement but rather a formal notice of the meetings themselves, including the agenda and resolutions to be voted on. The presence of detailed meeting notices, agenda items, and proxy instructions aligns with the category of Proxy Solicitation & Information Statement (PSI). The document length and content confirm it is not a brief announcement or a report publication notice. Therefore, the appropriate classification is PSI with high confidence.
2009-02-08 Hebrew (modern)
Annual General Meeting / Special Meeting
Regulatory Filings Classification · 98% confidence The document explicitly mentions holding a 'special meeting' on 11/03/2009 and refers to an 'EGM Notice' (Extraordinary General Meeting Notice) and includes an attached 'proxy statement'. This strongly indicates materials related to a shareholder meeting, specifically the notice and associated voting documents. The closest category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). While this is an EGM, AGM-R is the designated category for general meeting materials in the provided schema, especially when proxy/voting information is central. The document is an announcement/notice about the meeting, not the final voting results (DVA) or a proxy solicitation document itself (PSI), but rather the primary notice material. Given the context of a meeting notice, AGM-R is the most appropriate fit among the choices.
2009-02-08 English
Regulatory Filings 2009
Regulatory Filings
2009-02-05 English
Immediate Report
Board/Management Information Classification · 95% confidence The document is a notification about convening Extraordinary Shareholders' Meetings (EGMs) following a shareholder letter requesting various shareholder approvals, including director appointments, removals, share capital consolidation, increase, and ADR ratio amendment. It details the agenda items for the EGMs and the meeting logistics. There are no financial statements or detailed financial data presented, nor is this a report or earnings release. The content focuses on shareholder meeting arrangements and related corporate governance matters. Therefore, this document fits best under the category of Board/Management Information (MANG), as it announces changes in the company's board and management-related matters.
2009-02-05 Hebrew (modern)

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.